TITLE

ClinPlan Chooses BioClinica Optimizer for Clinical Supply Chain Simulation

PUB. DATE
July 2012
SOURCE
Biomedical Market Newsletter;7/26/2012, Vol. 21, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article informs that BioClinica Inc. and ClinPlan LLC has entered into a partnership for offering clinical supply chain simulation services to reduce drug waste and trial costs. It mentions the services offered by the company which include medical device innovation, electronic data capture and clinical trial management. It further informs that the investigational products for human clinical trials are manufactured and commercialized by ClinPlan.
ACCESSION #
79244794

 

Related Articles

  • BioClinica Partners with Paragon Solutions to Create Clinical Architecture.  // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1 

    The article provides information on the partnership between BioClinica Inc. and the company Paragon Solutions to create clinical architecture. Through this partnership BioClinica customers will be able to utilize Paragon's resources and expertise to support large-scale integration of...

  • BioClinica, Inc. to Participate in Upcoming Industry Events and Demonstrate Global Technology-Enhanced Capabilities.  // Biomedical Market Newsletter;5/21/2011, p112 

    The article reports on the announcement of BioClinica Inc. that the members of its team will participate, attend and speak at several upcoming industry conferences in April and May 2011. It notes that the company is known as the global provider of clinical trial management solutions in Newtown,...

  • BioClinica to Release 4th Quarter and Year-End 2011 Financial Results on Feb 9 2012.  // Biomedical Market Newsletter;1/7/2012, Vol. 21, p1 

    The article offers information related to BioClinica Inc. and an announcement made by it regarding release of its quarterly and year ending financial reports. BioClinica Inc. is also hosting a conference call for peoples on February 9, 2012. BioClinica Inc. is a leading global provider of...

  • Millennium Pharmaceutical Becomes First Licensed Customer for BioClinica's New Enterprise Demand Aggregator.  // Biomedical Market Newsletter;5/21/2011, p1036 

    The article reports that a technology agreement has been signed between BioClinica Inc., a global provider of clinical trial management solutions, and Takeda Oncology Co., a biopharmaceutical company, in 2011 in the U.S. Under the agreement, the two companies will be working on the release of...

  • MUNDIPHARMA RESEARCH CHOOSES BIOCLINICA CTMS.  // Worldwide Biotech;Apr2014, Vol. 26 Issue 4, p3 

    The article reports on the selection by Mundipharma Research to the OnPoint Clinical Trial Management System (CTMS) from BioClinica to its clinical trial management. It mentions that the CTMS was selected due to its highly adaptive design that complements the approach by Mundipharma Research to...

  • Harrison Clinical Research Selects BioClinica OnPoint CTMS.  // Biomedical Market Newsletter;1/21/2012, Vol. 21, p1 

    The article reports on the announcement by the clinical trial management solutions provider BioClinica Inc. regarding the agreement of the company with the contract research organization Harrison Clinical Research for the purpose of supporting clinical trial management system. The capabilities...

  • Grünenthal Selects BioClinica OnPoint Clinical Trial Management System.  // Biomedical Market Newsletter;3/7/2012, Vol. 21, p1 

    The article offers information on the signing of global license agreement by Grünenthal GmbH for OnPoint clinical trial management system of BioClinica Inc., to support ongoing clinical trials of BioClinica Inc. With the help of OnPoint CTMS of Bioclinica, clinical trial sponsors can easily...

  • Luitpold Pharmaceuticals Chooses BioClinica Express EDC.  // Biomedical Market Newsletter;8/7/2012, Vol. 21, p1 

    The article offers information on the selection of BioClinica Inc.'s Express Electronic Data Capture (EDC) system by Luitpold Pharmaceuticals Inc. for multiple upcoming clinical trials. According to Marc L. Tokars, vice president of Clinical Operations for Luitpold Pharmaceuticals Inc.,...

  • BioClinica Announces 3rd Qtr 2011 Financial Results.  // Biomedical Market Newsletter;11/16/2011, Vol. 21, p24 

    The article reports on the financial results of clinical trial management and technology solutions provider BioClinica Inc. for the third quarter and nine months ended September 30, 2011. The financial report for the 3 months ended September 30, 2011 include the 4.1-percent increase in service...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics